PATENT CLAIM ANALYSIS

Application Number: 15746018
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
It is an object of the present invention to provide utilization of a UCA1 gene that is a host regulatory factor that enhances replication and/or propagation of a vaccinia virus, in order to effectively carry out cancer virotherapy using the vaccinia virus. The present invention relates to: a method for predicting and evaluating the cancer therapeutic effects of a vaccinia virus, which comprises measuring the expression of a UCA1 gene in the cancer cells of a cancer patient, and then predicting that a vaccinia virus exhibits cancer therapeutic effects on the patient, when the UCA1 gene has been expressed therein; and a vaccinia virus into which a UCA1 gene has been expressibly introduced.

Claim (Index 3):
The method according to  claim 1 , wherein the vaccinia virus is an LC16 strain, an LC16mO strain, or an LC16m8 strain modified to allow the expression of a B5R gene.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.95161
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15038145', '14876195', '14792424', '11470951', '13470558']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6913883495075759
- 35 USC 102 Novelty (BERT): 0.5390336918594643
- Combined Prediction Score: 0.6761528837427647
- Mean Citation Score: 306.7217
- Max Citation Score: 377.19144
- Similarity Product: 317.6947022910404

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test